Darren Dulay
Family Medicine · Newburgh, INNPI 1497240428
Payments from drug & device makers
Across 53 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$242
- GSK$122
- Pfizer$107
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$79
- Novo Nordisk$70
- Lilly USA, LLC$59
- plus $186 from 10 others
What the payments were for
- Food & beverage$865100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $242 |
| GSK | 6 | $122 |
| Pfizer | 6 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $79 |
| Novo Nordisk | 5 | $70 |
| Lilly USA, LLC | 4 | $59 |
| Amgen | 3 | $42 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Almatica Pharma LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$865 in reported general payments places this provider in the 55th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 103 | $63,818 |
| JardianceEmpagliflozin | 70 | $58,298 |
| OzempicSemaglutide | 55 | $54,152 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $32,007 |
| MounjaroTirzepatide | 18 | $21,342 |
| FarxigaDapagliflozin Propanediol | 26 | $19,649 |
| TrulicityDulaglutide | 17 | $17,569 |
| Aimovig AutoinjectorErenumab-Aooe | 17 | $12,036 |
| MyrbetriqMirabegron | 11 | $11,779 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,558 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $8,810 |
| Novolog FlexpenInsulin Aspart | 23 | $8,133 |
| EntrestoSacubitril/Valsartan | 12 | $8,122 |
| SynjardyEmpagliflozin/Metformin Hcl | 13 | $7,285 |
| Tiotropium Bromide | 11 | $4,609 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $107 | $63,818103 claims |
| Novo NordiskOzempic | $70 | $54,15255 claims |
| Lilly USA, LLCMounjaro, Trulicity | $59 | $38,91135 claims |
| GSKTrelegy Ellipta | $122 | $32,00739 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $14 | $30,20742 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $17 | $1,343174 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Newburgh
- Renee Michelle GalenNewburgh$2.1M
- Ruston StoltzNewburgh$40K
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.